BIO International Convention, the world’s largest biotechnology event with over 20,000+ industry leaders from around the world, is taking place in Boston, Massachusetts from June 19-22, 2025. Boston will become the epicentre of innovation, with a united mission to collaborate, share knowledge and transform bold ideas into groundbreaking discoveries.
At Sussex Research Laboratories Inc., we are a chemistry-driven company and a globally recognized leading specialist in empowering therapeutic innovation through glycoscience. We apply our expertise in glycodesign, glycan and glycoconjugation chemistries over a wide range of therapeutic areas including vaccine development, protein and antibody engineering and targeted drug delivery. As a pioneer with over 25 years of experience, we offer an advanced product portfolio of enabling glycans and a range of CRO/CDMO services that support pharma and biopharma partners in applying glycotechnology to next-generation therapeutics. These include oligonucleotide, peptide, protein, lipid and small molecule therapeutics, as well as Lipid Nanoparticle (LNP) technologies for modern drug design and delivery.
We are honoured to be representing Team Ontario as part of the Canadian Delegation! Meet with Brady Clark (CEO & Founder) and Remmick So (COO), who will be on-site ready to discuss how we can support your innovation and research through glycoscience.
BIO International Convention 2025
